Popular Psoriasis News and Current Events | Page 12

Popular Psoriasis News and Current Events, Psoriasis News Articles.
Sort By: Most Relevant | Most Recent
Page 12 of 14 | 534 Results
Psoriasis patients face higher than average death risk after a heart attack
Heart attack patients with psoriasis are 26 percent more likely to die from cardiovascular disease, or suffer from recurrent heart attacks or strokes, and are 18 percent more likely to die from all causes than those without the inflammatory skin disease. Researchers studied nearly 50,000 patients who had experienced their first heart attack between 2002 and 2006, following the 462 patients with psoriasis for an average of 19.5 months and the 48,935 controls for an average of 22 months. (2011-09-12)

Abgenix reports positive clinical data with ABX-IL8 in Psoriasis
Abgenix, Inc. (Nasdaq: ABGX) reported results of its Phase I/II clinical trial with ABX-IL8, a fully human antibody therapy for psoriasis developed with the company's XenoMouse™ technology. ABX-IL8 was safe and well tolerated at all dose levels tested and that a dose-dependent improvement was seen in multiple measures of disease. (1999-11-30)

Chemical cousin of anti-anxiety drugs holds promise for psoriasis treatment
A new drug candidate previously shown to reduce harmful side effects of the autoimmune disease lupus also may be useful in treating psoriasis. (2004-12-09)

Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Provecta demonstrated minimal side effects, significant efficacy and bystander effect on melanoma tumors in stage III patients. (2007-09-18)

Discovery of immune cells that protect against multiple sclerosis offers hope for new treatment
Immune cells called dendritic cells, which were previously thought to contribute to the onset and development of multiple sclerosis, actually protect against the disease in a mouse model, according to a study published by Cell Press in the August issue of the journal Immunity. These new insights change our fundamental understanding of the origins of multiple sclerosis and could lead to the development of more effective treatments for the disease. (2012-08-16)

Skin-disease patients show brain immunity to faces of disgust
People with psoriasis -- an often distressing dermatological condition that causes lesions and red scaly patches on the skin -- are less likely to react to looks of disgust by others than people without the condition, new research has found. (2009-08-27)

Possible new cure for psoriasis
Cell biologists of the University of Bonn, in cooperation with the University of Leeds (U.K.) and industry may have discovered a new effective therapy for psoriasis: a specific group of what are known as metalloproteinase inhibitors can normalise the increased tendency of epidermis cells (keratinocytes) to divide, which is the cause of this unpleasant lepidosis. Their findings are now being published in the Journal of Investigative Dermatology (Vol. 123, No. 3). (2004-08-16)

LSUHSC awarded patent for compound inhibiting cancer and other diseases
Dr. Eugene Woltering, the James D. Rives Professor of Surgery and Neurosciences at LSU Health Sciences Center New Orleans School of Medicine, and Dr. Conrad Hornick, former LSUHSC professor of physiology, have been awarded a US patent for a compound to inhibit the formation of blood vessels critical to the growth of cancerous tumors and diseases like diabetic retinopathy, obesity and psoriasis. (2008-10-06)

New psoriasis drug is more effective than current treatment
A phase II clinical trial led by Northwestern Medicine investigators shows that a new psoriasis drug called guselkumab has greater efficacy than the current standard of care for the chronic skin condition. (2015-07-08)

International opinion-leaders provide most recent perspectives
Earlier diagnosis and more aggressive treatment of Immune-Mediated Inflammatory Disorders (I.M.I.D.), such as rheumatoid arthritis, multiple sclerosis and Crohn's disease, may offer the opportunity to prevent some of the more severe manifestations, as well as the progression of these diseases. (2004-07-20)

Closer to the source of the itch
Scientists at Hokkaido University are getting closer to understanding the underlying mechanisms that lead to psoriasis. (2016-05-25)

Acitretin therapy may help reduce nail psoriasis
Low-dose acitretin (a drug used to treat skin psoriasis) therapy appears to reduce nail psoriasis symptoms, according to a report in the March issue of Archives of Dermatology, one of the JAMA/Archives journals. (2009-03-16)

Scientists unmask genetic markers associated with psoriasis
Scientists at the University of Michigan Department of Dermatology, the U-M School of Public Health and their collaborators have found DNA (2009-01-25)

Psoriasis patients at high risk of diabetes
Patients with psoriasis are at high risk of new-onset diabetes mellitus, according to research presented at ESC Congress 2012. The findings were presented at the press conference by Dr Ole Ahlehoff from Copenhagen University Hospital, Gentofte, Denmark and at the scientific session by Usman KHALID. (2012-08-27)

Research identifies how inflammatory disease causes fatigue
New animal research in the Feb. 18 issue of the Journal of Neuroscience may indicate how certain diseases make people feel so tired and listless. Although the brain is usually isolated from the immune system, the study suggests that certain behavioral changes suffered by those with chronic inflammatory diseases are caused by the infiltration of immune cells into the brain. The findings suggest possible new treatment avenues to improve patients' quality of life. (2009-02-17)

Psoriasis associated with diabetes and high blood pressure in women
Women with psoriasis appear to have an increased risk for developing diabetes and hypertension (high blood pressure), according to a report in the April issue of Archives of Dermatology, one of the JAMA/Archives journals. (2009-04-20)

People with IBD more likely to suffer from debilitating respiratory and nerve disorders
According to two studies published today in the American Gastroenterological Association (AGA) journal Gastroenterology, people with inflammatory bowel disease are more prone to developing severe disorders of the respiratory and nervous systems. The studies found an increase in the prevalence of asthma, arthritis, chronic renal disease, multiple sclerosis and psoriasis, among other disorders. (2005-09-01)

Vigorous physical activity associated with reduced risk of psoriasis
A study of US women suggests that vigorous physical activity may be associated with a reduced risk of psoriasis, according to a report published online first by Archives of Dermatology, a JAMA Network publication. (2012-05-21)

Musculoskeletal center wins $2.2 million for drug safety
The UAB Center for Education and Research on Therapeutics has won a $2.2 million federal grant to study the risks and benefits of a class of drugs called (2008-11-18)

Natural signal holds promise for psoriasis, age-related skin damage
The body may hold a secret to normalizing skin cell growth that is over zealous in psoriasis and non-melanoma skin cancers and too slow in aging and sun-damaged skin, researchers say. (2007-06-28)

Study compares treatments for chronic plaque psoriasis
UV-A therapy was found to be more effective than narrowband UV-B therapy in treating patients with chronic plaque psoriasis, according to an article in the July issue of Archives of Dermatology. (2006-07-17)

Researchers at Mainz University explore new approach for treating Alzheimer's disease
It seems that a drug that is actually approved for treatment of the dermal disorder psoriasis stimulates the activity of the enzyme ADAM10 in the brain of Alzheimer's patients. (2014-12-07)

Glycerin may help skin disease, study finds
Glycerin, commonly found in skin care products because it attracts water and helps skin look better, may have therapeutic value as well, according to researchers at the Medical College of Georgia. (2003-12-02)

Green tea may help prevent autoimmune diseases
Green tea may help protect against autoimmune disease, Medical College of Georgia researchers say. (2007-04-19)

Phase III study results with Raptiva™ in the treatment of psoriasis presented at Annual AAD meeting
Genentech and XOMA announced positive results from a randomized Phase III clinical trial with RaptivaTM (efalizumab) that studied efficacy and safety in the treatment of adults with moderate-to-severe plaque psoriasis. The study results were presented during a session on emerging biologic therapies for psoriasis at the 61st annual American Academy of Dermatology meeting. (2003-03-24)

Target for obesity drugs comes into focus
Researchers at the University of Michigan have determined how the hormone leptin, an important regulator of metabolism and body weight, interacts with a key receptor in the brain. (2012-10-11)

New study shows smoking increases risk of psoriasis
Another disease can be added to the list of smoking-related disorders -- psoriasis. Researchers have found that smoking increases the risk of developing psoriasis, heavier smoking increases the risk further, and the risk decreases only slowly after quitting. Investigators from the Massachusetts General Hospital, Brigham and Women's Hospital, the Harvard School of Public Health, all in Boston, Mass., US, and Vancouver General Hospital, Vancouver, BC, Canada, have published the results in the November 2007 issue of The American Journal of Medicine. (2007-10-29)

More severe psoriasis explains the higher costs of care for men
Men often suffer from more severe cases of psoriasis than women, which may explain why the cost of care for men is higher. This is the conclusion of researchers at Sweden's Umeå University in a new study. (2013-05-15)

Sensible health warnings to stay out of sun may also be denying some people the benefits it provides
Are the effects of the sun bad for all people? In this week's BMJ, researchers say that the public should be educated on both the pros and cons of sunlight exposure, so that they can weigh up the associated risks for themselves. (1999-07-09)

JCI online early table of contents: July 6, 2009
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, July 6, 2009, in the JCI, including: Understanding the anticancer effects of vitamin D3; Immune cells linked to severe infant liver disease; Psoriasis-like inflammation: crucial role for the protein CCR6; First natural target for regulatory T cells expressing CD8; Marker protein causes poor outcome in lung cancer; and Linking energy production with energy requirements. (2009-07-06)

Study suggests that psoriasis may be associated with development of type 2 diabetes
A population-based study from the United Kingdom suggests that the common skin condition psoriasis may be a risk factor for the development of type 2 diabetes mellitus, according to a report published Online First by Archives of Dermatology, a JAMA Network publication. (2012-06-18)

Blocking Autoimmunity Naturally
Weizmann Institute scientists have discovered a mechanism that may lead to the development of a selective treatment for autoimmune disorders. (1999-03-15)

Use of vitamin A cream may prevent skin cancer
Use of topical tazarotene, a vitamin A derivative, has significant potential for the prevention of basal cell carcinoma in people predisposed to the disease, according to a study presented at the American Association for Cancer Research's (AACR) first annual Frontiers in Cancer Prevention Research meeting. The researchers found an 85 percent inhibition of both tumor number and size in the tazarotene-treated mice compared to mice administered a placebo. (2002-10-16)

Psoriasis, risk of depression in the US population
The chronic inflammatory skin condition psoriasis was associated with the risk of major depression, although the risk was unrelated to the severity of the disorder, according to an article published online by JAMA Dermatology. (2015-09-30)

Discovery of wound-healing genes in flies could mitigate human skin ailments
Biologists at UC San Diego have identified eight genes never before suspected to play a role in wound healing that are called into action near the areas where wounds occur. (2013-04-24)

Boston University School of Medicine professor honored by the Endocrine Society
Michael F. Holick, Ph.D., M.D., director of the General Clinical Research Center and professor of medicine, physiology and biophysics at Boston University School of Medicine, is this year's recipient of the Delbert A. Fisher Research Scholar Award from the Endocrine Society for his scholarly work on the history of endocrinology. As recipient of this award, Holick delivered the Clark T. Sawin Memorial History of Endocrinology Lecture at ENDO 2011 held last week in Boston. (2011-06-17)

Home UVB therapy for psoriasis as effective and safe as hospital treatment
For patients with psoriasis, treatment with ultraviolet B at home is as effective and as safe as conventional hospital based phototherapy, concludes a study published on bmj.com today. (2009-05-07)

UV-B treatment may improve psoriasis and vitamin D levels
Treatment with narrow-band UV-B rays may increase serum levels of vitamin D in the wintertime while clearing psoriasis, according to a report in the August issue of Archives of Dermatology, one of the JAMA/Archives journals. (2010-08-16)

Long-term apremilast demonstrates continued efficacy in patients with psoriatic arthritis
New data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism show that apremilast administered to patients with psoriatic arthritis continues to demonstrate meaningful clinical responses beyond 24 weeks. For patients who completed 52 weeks of the study, up to 65 percent achieved ACR20 response rates. Also, apremilast continued to be well tolerated with an acceptable longer-term safety profile. (2013-06-12)

Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
The first reported findings from an international, Phase 3 study showed that more than two-thirds of patients with moderate to severe plaque psoriasis receiving two doses of ustekinumab (CNTO 1275) achieved at least a 75 percent reduction in psoriasis at week 12, the primary endpoint of the study, as measured by the Psoriasis Area and Severity Index. (2007-10-03)

Page 12 of 14 | 534 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.